Cargando…

Tumor necrosis factor alpha inhibitors and demyelinating disease: what is behind it?

Detalles Bibliográficos
Autores principales:	Kucharz, Eugeniusz Józef, Kotulska-Kucharz, Anna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie 2021
Materias:	Editorial Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103413/ https://www.ncbi.nlm.nih.gov/pubmed/33976458 http://dx.doi.org/10.5114/reum.2021.105438

Ejemplares similares

Serum angiostatin and endostatin levels in patients with granulomatosis with polyangiitis and immune complex small vessel vasculitis
por: Kotulska-Kucharz, Anna, et al.
Publicado: (2018)

Osseous manifestations of sarcoidosis
por: Kucharz, Eugeniusz Józef
Publicado: (2020)

Mixed generalized/juxta-articular form of Dercum’s disease
por: Kucharz, Eugeniusz J., et al.
Publicado: (2016)

Correlation between erythrocyte sedimentation rate and C-reactive protein level in patients with rheumatic diseases
por: Kotulska, Anna, et al.
Publicado: (2015)

Calprotectin in rheumatic diseases: a review
por: Kopeć-Mędrek, Magdalena, et al.
Publicado: (2016)

Plasma Glycosaminoglycan Profiles in Systemic Sclerosis: Associations with MMP-3, MMP-10, TIMP-1, TIMP-2, and TGF-Beta
por: Kuźnik-Trocha, Kornelia, et al.
Publicado: (2020)

In memoriam Professor Ugo Efisio Francesco Carcassi
por: Kucharz, Eugeniusz J.
Publicado: (2016)

The 33(rd) World Congress of Internal Medicine: Nusa Dua, Indonesia, August 22–25, 2016
por: Kucharz, Eugeniusz J.
Publicado: (2016)

Sesquicentennial of the birth of Edmund Faustinus Biernacki, a discoverer of the erythrocyte sedimentation rate
por: Kucharz, Eugeniusz J.
Publicado: (2017)

The 11(th) Central European Congress of Rheumatology: Prague, December 8–10, 2016
por: Kucharz, Eugeniusz J.
Publicado: (2017)

Medical eponyms from linguistic and historical points of view
por: Kucharz, Eugeniusz Józï
Publicado: (2020)

Hit two birds with one stone: why crystalline glucosamine sulphate used for osteoarthritis medication is beneficial for patients with risk of cardiovascular disorders
por: Kucharz, Eugeniusz J.
Publicado: (2019)

Clinical manifestations of Whipple’s disease mimicking rheumatic disorders
por: Kucharz, Eugeniusz J., et al.
Publicado: (2021)

Tofacitinib in the treatment of patients with rheumatoid arthritis: position statement of experts of the Polish Society for Rheumatology
por: Kucharz, Eugeniusz J., et al.
Publicado: (2018)

Aggrecan Turnover in Women with Rheumatoid Arthritis Treated with TNF-α Inhibitors
por: Szeremeta, Anna, et al.
Publicado: (2020)

Opinion of patients with ankylosing spondylitis on risk factors impairing their quality of life
por: Kucharz, Eugene J., et al.
Publicado: (2012)

Dercum’s disease (adiposis dolorosa): a review of clinical presentation and management
por: Kucharz, Eugeniusz J., et al.
Publicado: (2019)

Ocular manifestations in patients with systemic sclerosis
por: Kozikowska, Małgorzata, et al.
Publicado: (2020)

Central Nervous System Demyelination Related to Tumour Necrosis Factor Alpha Inhibitor
por: Chey, Shin Yee, et al.
Publicado: (2022)

High acute phase protein levels correlate with pulmonary and skin involvement in patients with diffuse systemic sclerosis
por: Lis-Święty, Anna, et al.
Publicado: (2018)

Effect of adalimumab on the expression of genes encoding TNF-α signal paths in skin fibroblasts in vitro
por: Wcisło-Dziadecka, Dominika, et al.
Publicado: (2018)

VEXAS syndrome: a newly discovered systemic rheumatic disorder
por: Kucharz, Eugenisz J.
Publicado: (2023)

Effects of a 15-month anti-TNF-α treatment on plasma levels of glycosaminoglycans in women with rheumatoid arthritis
por: Szeremeta, Anna, et al.
Publicado: (2018)

Plasma leptin and neuropeptide Y concentrations in patients with rheumatoid arthritis treated with infliximab, a TNF-α antagonist
por: Kopec-Medrek, Magdalena, et al.
Publicado: (2011)

A human inhibitor of tumor necrosis factor alpha
Publicado: (1988)

Tumor necrosis factor-alpha inhibitor treatment for sarcoidosis
por: Callejas-Rubio, José Luis, et al.
Publicado: (2008)

Real-World Data from a Multi-Center Study: Insights to Psoriatic Arthritis Care
por: Batko, Bogdan, et al.
Publicado: (2021)

Biosimilar switching – current state of knowledge
por: Wiland, Piotr, et al.
Publicado: (2018)

Demyelinizing Neurological Disease after Treatment with Tumor Necrosis Factor-α Antagonists
por: Bruè, Claudia, et al.
Publicado: (2016)

The adverse drug reactions to tumor necrosis factor alpha inhibitor
por: Park, Hye-Kyung, et al.
Publicado: (2014)

Tumor Necrosis Factor Alpha Inhibitor-Induced Acute Pancreatitis
por: Werlang, Monia E., et al.
Publicado: (2017)

Phytochemicals as inhibitors of tumor necrosis factor alpha and neuroinflammatory responses in neurodegenerative diseases
por: Zahedipour, Fatemeh, et al.
Publicado: (2022)

Rational and homological equivalence of real algebraic cycles
por: Kucharz, W
Publicado: (2002)

Algebraic cycles and algebraic models of smooth manifolds
por: Kucharz, W
Publicado: (2000)

Algebraic equivalence of real divisors
por: Kucharz, W
Publicado: (2000)

Algebraic equivalence of cycles and algebraic models of smooth manifolds
por: Kucharz, W
Publicado: (2002)

CHLD score, a new score based on traditional risk factor evaluation and long-term cardiovascular outcomes in patients with systemic sclerosis
por: Gieszczyk-Strózik, Klaudia, et al.
Publicado: (2021)

Serum Levels of Tumor Necrosis Factor - alpha in Patients With Psoriasis
por: Ovcina-Kurtovic, Nermina, et al.
Publicado: (2022)

Behind the pathology of macrophage-associated demyelination in inflammatory neuropathies: demyelinating Schwann cells
por: Park, Hwan Tae, et al.
Publicado: (2019)

An Occult Malignancy Behind a Demyelinating Disease: POEMS Syndrome
por: Lo Presti, Saberio, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_27aemtlf3m56o7d50hccr29veu